Treatment-related myelodysplastic syndrome: molecular characteristics and therapy
about
Myelodysplastic syndromes: diagnosis, prognosis, and treatment.Simultaneous and sequential concurrent myeloproliferative and lymphoproliferative neoplasms.GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.Myelodysplastic syndrome: an inability to appropriately respond to damaged DNA?Prospective nested case-control study of feature genes related to leukemic evolution of myelodysplastic syndrome.
P2860
Treatment-related myelodysplastic syndrome: molecular characteristics and therapy
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Treatment-related myelodysplastic syndrome: molecular characteristics and therapy
@ast
Treatment-related myelodysplastic syndrome: molecular characteristics and therapy
@en
type
label
Treatment-related myelodysplastic syndrome: molecular characteristics and therapy
@ast
Treatment-related myelodysplastic syndrome: molecular characteristics and therapy
@en
prefLabel
Treatment-related myelodysplastic syndrome: molecular characteristics and therapy
@ast
Treatment-related myelodysplastic syndrome: molecular characteristics and therapy
@en
P2860
P1476
Treatment-related myelodysplastic syndrome: molecular characteristics and therapy
@en
P2093
Ravi Bhatia
P2860
P356
10.1097/MOH.0B013E328343997A
P577
2011-03-01T00:00:00Z